Status:

TERMINATED

SOLEMN Study - Synergy Optical Coherence Tomography in Left Main PCI

Lead Sponsor:

Jesse Brown VA Medical Center

Conditions:

Percutaneous Coronary Intervention

Optical Coherence Tomography

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

BACKGROUD: Percutaneous coronary intervention (PCI) is increasingly used to treat unprotected left main coronary artery stenosis. Protected LM PCI is considered standard of care in most centers. OCT...

Detailed Description

The proposed study is a multicenter, observational, prospective, single-arm study of stent strut coverage of patients undergoing LM PCI. Baseline quantitative coronary analysis (QCA) will be performe...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Age 18 years or greater;
  • Left Main CAD, defined as ≥ 50% diameter stenosis and amenable to re-vascularization by PCI;
  • Willing and able to give informed consent. The patients must be able to comply with study procedures and follow-up.
  • Ability to comply with minimum of 6 months of DAPT after the index procedure.
  • Unprotected Left Main PCI
  • Protected Left Main PCI
  • Exclusion criteria:
  • Coexisting conditions that limit life expectancy to less than 12 months or that could affect patient's compliance with the protocol;
  • Serum creatinine greater than 2.0 mg/dL;
  • Cardiogenic shock;
  • STEMI;
  • Non-STEMI, if the cardiac troponin is not stable or starting to decline;
  • Pregnancy;
  • Inability to take dual antiplatelet therapy for 6 months;
  • Any target lesion with previously placed stent.
  • Patients disqualified for CABG surgery.
  • Contraindications for OCT use:
  • Bacteremia or sepsis
  • Major coagulation system abnormalities
  • Severe hemodynamic instability or shock
  • Patients diagnosed with coronary artery spasm
  • Acute renal failure

Exclusion

    Key Trial Info

    Start Date :

    July 11 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 31 2020

    Estimated Enrollment :

    12 Patients enrolled

    Trial Details

    Trial ID

    NCT03474432

    Start Date

    July 11 2018

    End Date

    May 31 2020

    Last Update

    May 17 2024

    Active Locations (13)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 4 (13 locations)

    1

    Birmingham VA Medical Center

    Birmingham, Alabama, United States, 35233

    2

    Southern Arizona VA Health Care System

    Tucson, Arizona, United States, 85723

    3

    VA Long Beach Healthcare

    Long Beach, California, United States, 90822

    4

    San Francisco VA

    San Francisco, California, United States, 94121